The Bard PowerPort, an implanted port that feeds medicine into a vein, has no global settlement fund as of November 2026, according to Drugwatch's November 2026 update. Attorneys project a speculative future range of $30,000 to $350,000, tied to injury severity and evidence. More than 4,345 federal cases are centralized in Arizona as In re: Bard Implanted Port Catheter Litigation, MDL No.
3081. Doyle APC reports Judge David G. Campbell oversees the cases. Bellwether trials are testing representative claims to guide talks.
Official resource:
- Check eligibility on Legalclarity’s official study page — Use this page to check the study’s participation requirements.
Table of Contents
- Is there a settlement fund now?
- What have bellwether trials decided?
- What payment ranges are lawyers discussing?
- Who qualifies and what moves value?
Is there a settlement fund now?
No fund pays Bard PowerPort claims now. The cases remain in pretrial litigation, so no claim form creates a set average. Drugwatch states no global deal exists as of November 2026.
That status means plaintiffs receive nothing automatically. A lawyer must file an individual case and prove injury, defect, and cause. Any payment would come from a future deal, a trial verdict, or dismissal.
What have bellwether trials decided?
Results are mixed, with one large plaintiff win and two defense wins. The second bellwether jury awarded $40 million in compensatory damages on September 4, 2026, to Kimberly Divelbliss, reports MDL Update's bellwether tracker. Her catheter fractured and migrated to her heart. Bard won the other tried cases.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Cook ended in May 2026 with a defense verdict on warned claims and a hung jury on design defect. The Lattanzio infection case ended in a defense verdict reported October 30, 2026. The split matters for value. A fracture with heart migration drew a large award, while warned and infection claims faced tougher juries. Later verdicts can shift leverage for both sides.
What payment ranges are lawyers discussing?
Published ranges are estimates, not offers. The LegalClarity Team puts the commonly cited speculative span at $30,000 to $350,000 in LegalClarity's June 2026 analysis. Broader attorney talk runs from about $10,000 to $1 million.
Injury type drives the tiers. Reich & Binstock projects the pattern described in Reich & Binstock's August 2026 update: Strong proof of defect, removal surgery, and high bills push a case up. Weak causation, short treatment, or full recovery push it down.
- Infection-only case needing antibiotics or short hospital stay: about $30,000 to $100,000
- Fracture or migration needing fragment retrieval surgery or vascular repair: about $175,000 to $350,000 or more
- Clot, sepsis, or vessel and heart perforation with lasting harm: toward the top end
Who qualifies and what moves value?
Doyle APC describes eligible patients as people with a Bard PowerPort, BardPort, SlimPort, or X-Port who later had fracture, migration, infection or sepsis, clot, or vessel and heart perforation. Treatment often includes removal surgery, hospitalization, antibiotics, or blood thinners. Records must link the device to the harm.
Value turns on concrete losses and proof. The Lanier Law Firm points to medical costs, lost wages, pain, permanence, defect proof, and jury views of coming bellwethers. Hicks is set for December 1, 2026, and Sorensen for February 2, 2027. Those verdicts can raise or lower settlement pressure.
You Might Also Like
- Hair Relaxer Lawsuit Settlement: Deadlines Plaintiffs Face Before December
- Bard PowerPort Lawsuit Deadline: When Must You File a Claim?
- Tylenol Autism Lawsuit: What Plaintiffs Must Show to File a Claim?